Slingshot Insights

Catalyst

Slingshot members are tracking this event:

PDUFA Date in Early 2017 for Allergan (AGN) and Ironwood's (IRWD) Supplemental Application for 72 mcg Linzess in Treatment of IBS-C and Chronic Idiopathic Constipation

Source Link:: http://www.prnewswire.com/news-releases/ironwood-and-allergan-announce-supplemental-new-drug-application-for-72-mcg-linaclotide-in-chronic-idiopathic-constipation-has-been-accepted-for-fda-review-300282247.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

AGN

100%

IRWD

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Jan 26, 2017

Occurred Source:

http://finance.yahoo.com/news/u-food-drug-administration-approves-120100169.html

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Pdufa, Supplemental Applciation, Linzess, 72 Mcg, Irritable Bowel Syndrome With Constipation, Ibs-c, Chronic Idiopathic Constipation, Cic